Theriva Biologics
TOVX
TOVX
23 hedge funds and large institutions have $1.61M invested in Theriva Biologics in 2018 Q4 according to their latest regulatory filings, with 7 funds opening new positions, 2 increasing their positions, 6 reducing their positions, and 6 closing their positions.
New
Increased
Maintained
Reduced
Closed
more first-time investments, than exits
New positions opened: | Existing positions closed:
more funds holding
Funds holding: →
more ownership
Funds ownership: →
less capital invested
Capital invested by funds: $ → $
67% less repeat investments, than reductions
Existing positions increased: 2 | Existing positions reduced: 6
Holders
23
Holding in Top 10
–
Calls
$2.93M
Puts
–
Top Buyers
| 1 | +$626K | |
| 2 | +$312K | |
| 3 | +$171K | |
| 4 |
AFM
Anson Funds Management
Dallas,
Texas
|
+$88K |
| 5 |
BFM
Boothbay Fund Management
New York
|
+$34K |
Top Sellers
| 1 | -$52.9K | |
| 2 | -$49K | |
| 3 | -$29K | |
| 4 |
VF
Virtu Financial
New York
|
-$12.3K |
| 5 |
MAM
Meeder Asset Management
Dublin,
Ohio
|
-$7K |